CHICAGO/NEW YORK (Reuters) - Two other drugs made by the Massachusetts pharmacy at the center of a deadly meningitis outbreak may be linked to the disease, U.S. health regulators said on Monday, potentially widening the scope of the health crisis. The Food and Drug Administration said it was looking into reports of a patient with possible meningitis who received an injection of a different ...
